CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Grant or award Director acquired 6,464 shares (grant or award)
- 4 Grant or award Director acquired 6,464 shares (grant or award)
- 4 Grant or award Director acquired 6,464 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 24,648 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 35,211 shares (grant or award)
- 4 Grant or award See Remarks acquired 35,211 shares (grant or award)
- 4 Grant or award See Remarks acquired 134,976 shares (grant or award)
- 4 Planned sale Director sold 11,931 shares at $13.14 ($156,733)
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Open-market sale See Remarks sold 82,648 shares at an average $9.95 ($822,396)
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Former 10% Owner sold 1,690,663 shares at $7.50 ($12,679,973)
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 9 of 28 · 558 filings